CNBG donates COVID-19 vaccines to Wuhan; CanSinoBIO recruits Wuhan volunteers to test injection location - (Global Times via NewsPoints Desk)

  • China National Biotech Group (CNBG), whose two inactivated candidate COVID-19 vaccines are in Phase III trials, donated 200,000 doses of the candidate vaccines to Wuhan, China, that will be used on medical staff on the frontlines of the pandemic, reported the Global Times.

  • The vaccine candidates have demonstrated safety and efficacy in Phase I/II clinical trials and have obtained urgent usage by national authorities, said CNBG chairman Yang Xiaoming.

  • The two candidates are now undergoing Phase III clinical trials in more than ten countries, including the United Arab Emirates, Egypt and Peru, with more than 50,000 volunteers being vaccinated, according to CNBG.  

  • The company previously said its COVID-19 vaccines were expected to come onto the market by the end of this year. 

To read more NewsPoints articles, click here.